Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

>"In the third quarter Lilly continued to drive revenue growth for many key brands, including Cymbalta, Humalog, Forteo and Strattera, with strong growth also seen in animal health, Japan and China. This growth offset the continued erosion of Gemzar sales due to generic competition," said John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "As we face the loss of patent exclusivity for Zyprexa in most major markets, we are well-prepared as a company to meet the challenges before us. We remain committed to our innovation-based strategy and are focused on delivering the next wave of new medicines to patients in the coming years."

Key Events Over the Last Three Months

  • The European Commission granted marketing authorization for Trajenta® for the treatment of adults with type 2 diabetes. The company and its partner Boehringer Ingelheim have recently begun launching Trajenta in the European Union, beginning with the United Kingdom.

  • The U.S. Food and Drug Administration (FDA) approved Cialis® tablets for once daily use for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (ED+BPH). The FDA also approved Cialis for once daily use for a separate indication for the treatment of the signs and symptoms of BPH.

  • The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for the use of Alimta® as continuation maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer (NSCLC).

  • The U.S. Court of Appeals for the Federal Circuit overturned a prior ruling by the U.S. District Court for the District of New Jersey and upheld the validity of the company's method-of-use patent on Strattera®. The method-of-use patent provides protection for Strattera through May of 2017.

  • The company, along with its partners Amylin Pharmaceutic
    '/>"/>

  • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Declares Fourth-Quarter 2011 Dividend
    2. Lilly Announces Changes in Senior Management
    3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
    4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
    5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
    6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
    7. Lilly Health Channel Debuts on YouTube
    8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
    9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
    10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
    11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)... , July 28, 2015   Vincari , known ... , has just hired John O,Neil as ... John has over 30 years of diverse and progressive ... O,Neil,s executive healthcare experience coupled with Vincari,s CMO, Dr. ... allows Vincari to address the challenges both hospitals and ...
    (Date:7/28/2015)... ALBANY, New York , July 28, 2015 ... of a new report, titled " Cancer Diagnostics ... Forecast, 2014 - 2020 " . According to this ... at a CAGR of 7.6% during the forecast period of ... was valued at US$100,994.5 million and is expected to be ...
    (Date:7/28/2015)... 2015   CSL Behring announced today ... Authorization Application (MAA) for the company,s investigational long-acting ... recombinant albumin (rIX-FP) for the prophylaxis and treatment ... Upon Swissmedic approval, rIX-FP will provide hemophilia B ... intervals up to 14 days. ...
    Breaking Medicine Technology:John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4
    ... 2010 Reportlinker.com announces that a new market research ... Chinese Markets for Drug Delivery System ... demand for Drug Delivery System has grown at a ... five years, both production and demand will continue to ...
    ... GARDENS, Fla., Dec. 9, 2010 The national media keeps ... results of the NYU one-year research study on pediatric dosing ... Journal of the American Medical Association ,s December issue. The ... top children,s liquid medications, found inconsistencies across all the medications, ...
    Cached Medicine Technology:Reportlinker Adds Chinese Markets for Drug Delivery System 2Reportlinker Adds Chinese Markets for Drug Delivery System 3Reportlinker Adds Chinese Markets for Drug Delivery System 4Reportlinker Adds Chinese Markets for Drug Delivery System 5AccuDial® Pharmaceutical Solves OTC Dosing Errors for Children's Liquid Medications 2AccuDial® Pharmaceutical Solves OTC Dosing Errors for Children's Liquid Medications 3
    (Date:7/28/2015)... ... July 29, 2015 , ... City Sports, a specialty sports retailer and ... executive Marty Hanaka as CEO. , Hanaka, who has served on the Board of ... partner at the Highland Consumer Fund has had previous tenures as Chairman and CEO ...
    (Date:7/28/2015)... West Jordan, Utah (PRWEB) , ... July 28, ... ... Medical Center West Valley Campus have received the Get With The Guidelines®-Stroke Gold ... Association for excellence in patient care and outcomes. , The Get With ...
    (Date:7/28/2015)... Rolling Meadows, Ill. (PRWEB) , ... July 28, 2015 , ... ... has been commended with a national 2015 Power of A award for “helping to ... named a Power of A Gold Award winner by the American Society of Association ...
    (Date:7/28/2015)... , ... July 28, 2015 , ... ... navigation, portal to access industry practices, consumer education, resource library, floor plans, educational ... from around the globe and offers regular posts with valuable links to useful ...
    (Date:7/28/2015)... Richey, FL (PRWEB) , ... July 28, 2015 ... ... University and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance ... the latter group was more likely to relapse to opiate use (1) and ...
    Breaking Medicine News(10 mins):Health News:City Sports Names Marty Hanaka CEO 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 3Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4
    ... Komen NC Triangle Affiliate Joins Nationwide Campaign to Close ... Low-Income Women and Women of Color, RALEIGH, N.C., ... G. Komen for the Cure today joined Governor Easley ... proclamation and a,Monday evening Executive Mansion reception with First ...
    ... Evening Will Feature Special Performances by John Legend, Joss Stone, ... Patti ... G&P Foundation for Cancer,Research will honor four outstanding individuals at the ... Officer of BET Networks Debra L. Lee, Chief Hematologic Oncology,Memorial Sloan-Kettering ...
    ... researchers say , TUESDAY, Oct. 16 (HealthDay News) -- ... and sashimi -- increases the risk of infection by ... stomach and intestinal problems such as diarrhea, cramping, and ... department, say two cases studies by Japanese researchers. , ...
    ... 2007 -- Scientists have shown how developing brain tumors can ... experience for the tumor cells into a cue for their ... of Medicine in St. Louis found the transformation relies on ... existing drugs, opening the possibility that they may be able ...
    ... pylori has been extensively studied and proven to be the ... HIV-negative population. Patients with chronic active gastritis have evidence of ... 70-100% of those with peptic ulcer disease. However, the reason ... was still not very clear. A study examining this issue ...
    ... are diagnosed with breast cancer is predicting the likelihood ... the body metastasize. Researchers from UC San Diego ... Ideker is pioneering a more accurate approach for predicting ... , This work will be published online by the ...
    Cached Medicine News:Health News:Susan G. Komen for the Cure Launches Komen Community Challenge With Governor's Pink Ribbon Week Proclamation and Executive Mansion Reception 2Health News:Susan G. Komen for the Cure Launches Komen Community Challenge With Governor's Pink Ribbon Week Proclamation and Executive Mansion Reception 3Health News:Susan G. Komen for the Cure Launches Komen Community Challenge With Governor's Pink Ribbon Week Proclamation and Executive Mansion Reception 4Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 3Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 4Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 5Health News:Raw Seafood Poses Digestive Risks 2Health News:Study suggests existing drugs may be useful in treating brain tumors 2Health News:Study suggests existing drugs may be useful in treating brain tumors 3Health News:A low prevalence of H pylori in HIV-positive patients 2Health News:UC San Diego researchers improve accuracy of breast cancer prognoses 2Health News:UC San Diego researchers improve accuracy of breast cancer prognoses 3
    The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
    Quatroloc Revision Hip System...
    Severe revision options for the knee and hip...
    Severe revision options for the knee and hip...
    Medicine Products: